These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38372161)

  • 21. Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer's disease progression.
    De S; Whiten DR; Ruggeri FS; Hughes C; Rodrigues M; Sideris DI; Taylor CG; Aprile FA; Muyldermans S; Knowles TPJ; Vendruscolo M; Bryant C; Blennow K; Skoog I; Kern S; Zetterberg H; Klenerman D
    Acta Neuropathol Commun; 2019 Jul; 7(1):120. PubMed ID: 31349874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of Thiophene-Based Optical Ligands That Selectively Detect Tau Pathology in Alzheimer's Disease.
    Shirani H; Appelqvist H; Bäck M; Klingstedt T; Cairns NJ; Nilsson KPR
    Chemistry; 2017 Dec; 23(67):17127-17135. PubMed ID: 28926133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain].
    Watanabe H
    Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catalytic Prion-Like Cross-Talk between a Key Alzheimer's Disease Tau-Fragment R3 and the Type 2 Diabetes Peptide IAPP.
    Arya S; Claud SL; Cantrell KL; Bowers MT
    ACS Chem Neurosci; 2019 Nov; 10(11):4757-4765. PubMed ID: 31642657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoscale Characterization of Parallel and Antiparallel β-Sheet Amyloid Beta 1-42 Aggregates.
    Zhaliazka K; Kurouski D
    ACS Chem Neurosci; 2022 Oct; 13(19):2813-2820. PubMed ID: 36122250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tip-Enhanced Raman Spectroscopy to Distinguish Toxic Oligomers from Aβ
    Bonhommeau S; Talaga D; Hunel J; Cullin C; Lecomte S
    Angew Chem Int Ed Engl; 2017 Feb; 56(7):1771-1774. PubMed ID: 28071842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. βAPP Processing Drives Gradual Tau Pathology in an Age-Dependent Amyloid Rat Model of Alzheimer's Disease.
    Audrain M; Souchet B; Alves S; Fol R; Viode A; Haddjeri A; Tada S; Orefice NS; Joséphine C; Bemelmans AP; Delzescaux T; Déglon N; Hantraye P; Akwa Y; Becher F; Billard JM; Potier B; Dutar P; Cartier N; Braudeau J
    Cereb Cortex; 2018 Nov; 28(11):3976-3993. PubMed ID: 29048465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of size distribution and (Pro249-Ser258) epitope exposure in in vitro and in vivo derived Tau fibrils.
    Marreiro A; Van Kolen K; Sousa C; Temmerman L; Vasconcelos B; Crespo-Rodriguez R; van Weering JRT; Van Dam D; De Deyn PP; Apetri A; Schoofs L; Mercken MH
    BMC Mol Cell Biol; 2020 Nov; 21(1):81. PubMed ID: 33183222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tau Protein Aggregation in Alzheimer's Disease: Recent Advances in the Development of Novel Therapeutic Agents.
    Monteiro KLC; Alcântara MGDS; de Aquino TM; da Silva-Júnior EF
    Curr Pharm Des; 2020; 26(15):1682-1692. PubMed ID: 32286939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease.
    Uddin MS; Kabir MT; Niaz K; Jeandet P; Clément C; Mathew B; Rauf A; Rengasamy KRR; Sobarzo-Sánchez E; Ashraf GM; Aleya L
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32168835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Super-Resolution Microscopy of Cerebrospinal Fluid Biomarkers as a Tool for Alzheimer's Disease Diagnostics.
    Zhang WI; Antonios G; Rabano A; Bayer TA; Schneider A; Rizzoli SO
    J Alzheimers Dis; 2015; 46(4):1007-20. PubMed ID: 25881910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The search for a unique Raman signature of amyloid-beta plaques in human brain tissue from Alzheimer's disease patients.
    Lochocki B; Morrema THJ; Ariese F; Hoozemans JJM; de Boer JF
    Analyst; 2020 Mar; 145(5):1724-1736. PubMed ID: 31907497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models.
    Iyaswamy A; Wang X; Krishnamoorthi S; Kaliamoorthy V; Sreenivasmurthy SG; Kumar Durairajan SS; Song JX; Tong BC; Zhu Z; Su CF; Liu J; Cheung KH; Lu JH; Tan JQ; Li HW; Wong MS; Li M
    Redox Biol; 2022 May; 51():102280. PubMed ID: 35286997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fourier Transform Infrared (FTIR) Spectroscopy, Ultraviolet Resonance Raman (UVRR) Spectroscopy, and Atomic Force Microscopy (AFM) for Study of the Kinetics of Formation and Structural Characterization of Tau Fibrils.
    Ramachandran G
    Methods Mol Biol; 2017; 1523():113-128. PubMed ID: 27975247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tau protein aggregation: Key features to improve drug discovery screening.
    Giovannini J; Smeralda W; Jouanne M; Sopkova-de Oliveira Santos J; Catto M; Voisin-Chiret AS
    Drug Discov Today; 2022 May; 27(5):1284-1297. PubMed ID: 35085785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical Evaluation of
    Honer M; Gobbi L; Knust H; Kuwabara H; Muri D; Koerner M; Valentine H; Dannals RF; Wong DF; Borroni E
    J Nucl Med; 2018 Apr; 59(4):675-681. PubMed ID: 28970331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Key Peptides and Proteins in Alzheimer's Disease.
    Penke B; Bogár F; Paragi G; Gera J; Fülöp L
    Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. De novo designed protein inhibitors of amyloid aggregation and seeding.
    Murray KA; Hu CJ; Griner SL; Pan H; Bowler JT; Abskharon R; Rosenberg GM; Cheng X; Seidler PM; Eisenberg DS
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2206240119. PubMed ID: 35969734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents.
    Jouanne M; Rault S; Voisin-Chiret AS
    Eur J Med Chem; 2017 Oct; 139():153-167. PubMed ID: 28800454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating effect of metallic ions on aggregation behavior of β-amyloid peptides by atomic force microscope and surface-enhanced Raman Scattering.
    Xie Y; Yu L; Fu Y; Sun H; Wang J
    Biomed Eng Online; 2021 Dec; 20(1):132. PubMed ID: 34969380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.